Treating tuberculosis in developing countries.

Epidemiological Burden of Tuberculosis in Developing Countries

Tuberculosis (TB) is an infectious disease caused by different species of the genus Mycobacte‐ ria. Together with human immunodeficiency virus infection (HIV)/Acquired Immunodefi‐ ciency Syndrome (AIDS) and malaria, tuberculosis is one of the biggest killers in the Word (Rodríguez-Morales AJ et al 2008, Murcia-Aranguren MI et al 2001). Human disease is usu‐ ally caused by Mycobacterium tubercul...

Treating Schizophrenia with DOTS in Developing Countries: Author's Reply

Renato Souza, Silvia Yasuda, Susanna Cristofani Although DOTS is advocated as the best approach for global tuberculosis control, the variable success of this strategy [1] should help us in learning which problems we might face while adopting the same strategy for the treatment of schizophrenia in developing countries, as Dr. Farooq suggests [2]. Our experience of integrating mental health into ...

Saving lives by treating epilepsy in developing countries.

Tuberculosis in renal transplant recipients: challenges in developing countries.

Correspondence to: João Egidio Romão Junior. Clínica de Nefrologia e Transplantes, Beneficência Portuguesa Hospital. Rua Maestro Cardim, no 560, cj 172, SP, Brasil. CEP: 01323-001. E-mail: [email protected] The number of kidney transplanted patients has grown significantly in developing countries, primarily driven by an epidemic of chronic kidney disease.1 In Brazil alone, over 100,000 pat...

Zoonotic tuberculosis due to Mycobacterium bovis in developing countries.

The World Health Organization (WHO) estimates that human tuberculosis (TB) incidence and deaths for 1990 to 1999 will be 88 million and 30 million, respectively, with most cases in developing countries. Zoonotic TB (caused by Mycobacterium bovis) is present in animals in most developing countries where surveillance and control activities are often inadequate or unavailable; therefore, many epid...